Phase 3 clinical trial results lead to approval of oral drug for red blood cell disorder
Researchers have published the results of a clinical trial that led the U.S. Food and Drug Administration to recently approve mitapivat for the treatment of adults with pyruvate kinase deficiency—a rare genetic condition ...
Apr 14, 2022
0
31